{
  "id": 18093020,
  "title": "ROCK inhibitor Ripasudil reduces Alzheimer pathological proteins and enhances cellular bioenergetics",
  "url": "https://urgent.news/2026/11/03/rock-inhibitor-ripasudil-reduces-alzheimer-pathological-proteins-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.02.761117v1?rss=1"
  },
  "original_language": "en",
  "account": "Rho-associated kinase (ROCK) inhibitors, like ripasudil, have shown promise as potential treatments for Alzheimer's disease (AD). In this study, the researchers sought to assess the effectiveness of ripasudil on AD-related pathological proteins in mice. After administering ripasudil to AppNL-G-F knock-in mice at a dose of 30 mg/kg, the investigators analyzed the proteomic profiles of the treated mice's brains and compared them to those of untreated mice. Additionally, they treated human neural stem cells derived from AD patients with ripasudil and evaluated the impact on mitochondrial activity using a Seahorse Mito Stress Test.\n\nThe study's results indicated that ripasudil rapidly reached maximum concentration in the mouse brains within half an hour of injection. Bioinformatics analysis of the proteomic profiles revealed alterations in the expression of chromosome components. Furthermore, the Mito Stress Test of the AD-patient-derived neural stem cells treated with ripasudil demonstrated significant improvements in basal oxygen consumption, ATP-linked respiration, maximal respiration, and reserve capacity oxygen consumption compared to untreated cells. Crucially, the researchers observed a significant reduction in tau and phosphorylated tau 396 in the brains of mice treated with ripasudil.\n\nThese findings suggest that ripasudil may serve as a feasible and promising therapeutic agent for AD, given its ability to reduce pathological tau protein levels and enhance cellular bioenergetics.",
  "summary": "Rho-associated kinase (ROCK) inhibitors have been explored as an Alzheimer Disease (AD) therapeutic agent. In this study, we aim to determine the efficacy of a potent ROCK inhibitor, ripasudil, in impacting AD pathological protein tau in mice. The time-course study showed that ripasudil rapidly penetrated mouse brains, reaching maximal concentration half an hour post-injection. To determine the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "ScienceDaily Health",
        "title": "Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation",
        "url": "https://urgent.news/2026/11/03/scientists-discover-new-alzheimers-drug-that-repairs-dna-damage-and",
        "published": "2026-11-03T04:11:58.000Z"
      },
      {
        "outlet": "New Scientist",
        "title": "Vibrating mattress helps clear Alzheimer’s protein from the brain",
        "url": "https://urgent.news/2026/11/03/vibrating-mattress-helps-clear-alzheimers-protein-from-the-brain",
        "published": "2026-11-03T10:00:00.000Z"
      },
      {
        "outlet": "PsyPost",
        "title": "New brain atlas reveals thousands of overlooked microproteins linked to Alzheimer’s disease",
        "url": "https://urgent.news/2026/11/03/new-brain-atlas-reveals-thousands-of-overlooked-microproteins-linked",
        "published": "2026-11-03T21:00:34.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}